Emergingby Glyph$435M
Led by Founders Fund
NewLimit
StartupUSfounded 20211 field
Where it works
| Technology | ||
|---|---|---|
| Longevity biotechDevelops epigenetic reprogramming medicines to restore youthful function in old cells, starting with the liver. | Develops epigenetic reprogramming medicines to restore youthful function in old cells, starting with the liver. | blog.newlimit.com |
Funding
About
- Source
- blog.newlimit.com (official, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Oct 6, 2026
- Across Glyph
- NewLimit on Companies